Anatomically interpretable deep learning of brain age captures domain-specific cognitive impairment.
Chenzhong YinPhoebe ImmsMingxi ChengAnar AmgalanNahian F ChowdhuryRoy J MassettNikhil N ChaudhariXinghe ChenPaul M ThompsonPaul BogdanAndrei Irimianull nullPublished in: Proceedings of the National Academy of Sciences of the United States of America (2023)
The gap between chronological age (CA) and biological brain age, as estimated from magnetic resonance images (MRIs), reflects how individual patterns of neuroanatomic aging deviate from their typical trajectories. MRI-derived brain age (BA) estimates are often obtained using deep learning models that may perform relatively poorly on new data or that lack neuroanatomic interpretability. This study introduces a convolutional neural network (CNN) to estimate BA after training on the MRIs of 4,681 cognitively normal (CN) participants and testing on 1,170 CN participants from an independent sample. BA estimation errors are notably lower than those of previous studies. At both individual and cohort levels, the CNN provides detailed anatomic maps of brain aging patterns that reveal sex dimorphisms and neurocognitive trajectories in adults with mild cognitive impairment (MCI, N = 351) and Alzheimer's disease (AD, N = 359). In individuals with MCI (54% of whom were diagnosed with dementia within 10.9 y from MRI acquisition), BA is significantly better than CA in capturing dementia symptom severity, functional disability, and executive function. Profiles of sex dimorphism and lateralization in brain aging also map onto patterns of neuroanatomic change that reflect cognitive decline. Significant associations between BA and neurocognitive measures suggest that the proposed framework can map, systematically, the relationship between aging-related neuroanatomy changes in CN individuals and in participants with MCI or AD. Early identification of such neuroanatomy changes can help to screen individuals according to their AD risk.
Keyphrases
- mild cognitive impairment
- cognitive decline
- convolutional neural network
- deep learning
- resting state
- white matter
- magnetic resonance
- cognitive impairment
- functional connectivity
- lymph node metastasis
- depressive symptoms
- magnetic resonance imaging
- contrast enhanced
- cerebral ischemia
- artificial intelligence
- machine learning
- multiple sclerosis
- computed tomography
- bipolar disorder
- gene expression
- genome wide
- optical coherence tomography
- squamous cell carcinoma
- high throughput
- subarachnoid hemorrhage
- patient safety
- big data
- quality improvement
- diffusion weighted imaging